Cover Image

The Role of Single-Cell Multi-omics and Artificial Intelligence in Guiding Precision Antibody-Drug Conjugate Therapies for Metastatic Breast Cancer.

Fuente: Zenodo

Saved in:

Bibliographic Details
Main Authors:	Krupa J, Afreen Misbah, Ajoy Shil, Santanu Mandal
Format:	Recurso digital
Published:	Zenodo 2025
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ICAM‐1 Is Overexpressed by Cancers and Negatively Impacts Antibody‐Based Therapies Including Antibody–Drug Conjugates
by: J. Bradford Kline, et al.
Published: (2025)

Unlocking Natural Potential: Antibody‐Drug Conjugates With Naturally Derived Payloads for Cancer Therapy
by: Xue Jiang, et al.
Published: (2024)

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer
by: Minji Seo, et al.
Published: (2026)

Magnetic Nanoparticle‐Mediated Multimodal Cancer Therapy: Hyperthermia, Controlled Drug Release, and Antibody‐Based Precision
by: S. S. Pawar, et al.
Published: (2024)

Artificial Intelligence-Enhanced Couinaud Segmentation for Precision Liver Cancer Therapy
by: Qiu, Liang, et al.
Published: (2024)

A Self‐Assembled Protein Platform for Plug‐and‐Play Customization of Multivalent Artificial Antibodies and Antibody‐Drug Conjugates
by: Yuzhe Chen, et al.
Published: (2025)

MGL‐Based Drug Conjugate: A Novel Glycan‐Targeting Strategy for Potential Precision Cancer Therapy
by: Carlos D. L. Lima, et al.
Published: (2026)

Bioactives and Nanocarriers: Merging Frontiers in Cancer Therapy
by: Debolina Basu, et al.
Published: (2025)

Precise HER2 Protein Degradation via Peptide‐Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy
by: Changyong Guo, et al.
Published: (2024)

Population Pharmacokinetic Modeling and Exposure–Response Analysis for the Antibody–Drug Conjugate Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Carcinoma
by: Peiying Zuo, et al.
Published: (2024)

Artificial Intelligence‐Based Pathology to Assist Prediction of Neoadjuvant Therapy Responses for Breast Cancer
by: Juan Ji, et al.
Published: (2025)

Cytoplasmic Viscosity is a Potential Biomarker for Metastatic Breast Cancer Cells
by: Dessard, Marie, et al.
Published: (2024)

Breast Cancer: Molecular Pathogenesis and Targeted Therapy
by: Md Abdus Samad, et al.
Published: (2025)

Targeting Hyperglycemic Bone Pre‐Metastatic Niche for Breast Cancer Bone Metastasis Therapy
by: Jianxin Ye, et al.
Published: (2025)

Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment
by: Zhengjie Zhao, et al.
Published: (2024)

Metastatic Lobular Breast Cancer: Outcomes of Patients Treated at a Single Tertiary Institution
by: Ek Leone Oh, et al.
Published: (2025)

Arming Abraxane With Cationic Spermidine Conjugate and Homologous Cell Membrane for Enhanced Triple‐Negative Breast Cancer Therapy
by: Yilu Zheng, et al.
Published: (2026)

Predictive Role of Serum Inflammatory Markers in Metastatic Luminal A/B Breast Cancers Receiving CDK‐4/6 Inhibitors Therapy
by: Nilufer Bulut, et al.
Published: (2026)

Metastatic Prostate Cancer Masquerading as Locally Advanced Breast Cancer
by: Tess Howard, et al.
Published: (2026)

Frontispiz: Platelet‐Drug Conjugates Engineered via One‐step Fusion Approach for Metastatic and Postoperative Cancer Treatment
by: Zhengjie Zhao, et al.
Published: (2024)

Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
by: Yaxin Lei, et al.
Published: (2025)

Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease
by: Yeongji Jang, et al.
Published: (2025)

Evaluation of Potency and Specificity of Cryptophycin‐Loaded Antibody‐Drug Conjugates
by: Peter Bitsch, et al.
Published: (2024)

Engineered Macrophage Exosomes Deliver Drug‐Targeted Therapy for Breast Cancer
by: Mingrui Feng, et al.
Published: (2024)

Survival Outcomes in Breast Cancer Patients With Metastatic Bone Disease
by: Gerard J. Hill, et al.
Published: (2025)

Role of Artificial Intelligence in Oral Cancer
by: Vidhya Rekha Umapathy, et al.
Published: (2024)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
by: William L. Baker, et al.
Published: (2026)

Artificial Intelligence and Breast Cancer Management: From Data to the Clinic
by: Kaixiang Feng, et al.
Published: (2025)

Advanced Antibody–Drug Conjugates Design: Innovation in Linker Chemistry and Site‐Specific Conjugation Technologies
by: Yutaka Matsuda, et al.
Published: (2025)

OCT‐2 Is Associated With Pro‐Metastatic Epigenomic Properties of Triple‐Negative Breast Cancer Cells
by: Kazuki Ogikubo, et al.
Published: (2025)

Stochastic Time‐Resolved Opto‐Electrochemical Analysis of Free Nanourchin‐Conjugated Antibody Interactions With Breast Cancer Biomarkers in Serum
by: Mohammad E. Khosroshahi, et al.
Published: (2026)

Optimizing Body Size‐Based Dosing Approaches for Antibody–Drug Conjugates
by: Andrew B. SyBing, et al.
Published: (2025)

Learnings from Approved Antibody‐Drug Conjugates: Clinical Pharmacology Perspectives
by: Bhargavi Thalluri, et al.
Published: (2026)

Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates
by: Dian Xiao, et al.
Published: (2024)

Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions
by: Bisheng Cheng, et al.
Published: (2026)

Genetically Engineered Light‐Responsive In Situ Hydrogels for Immunomodulation and Multimodal Therapy in Metastatic Triple‐Negative Breast Cancer
by: Xinchen Shen, et al.
Published: (2025)

Influence of Hypertension Management on Survival in Patients With Metastatic Breast Cancer
by: Reina Haque, et al.
Published: (2026)

Antibody‐Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy
by: Brijesh Parlekar, et al.
Published: (2026)

Comments on “Ultrasound‐Mediated Nanocarrier‐Based Drug Delivery in Breast Cancer Therapy”
by: Deniz Esin Tekcan Sanli, et al.
Published: (2025)

Exploring the Potential of Mitochondria‐Targeted Drug Delivery for Enhanced Breast Cancer Therapy
by: Yalda Ghazizadeh, et al.
Published: (2025)